Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus
Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus
Primary:

 -  To compare the efficacy and safety of Insulin Glulisine to Insulin Lispro in subjects
 with type 1 or type 2 diabetes mellitus.

 -  To compare the frequency of hypoglycemia of Insulin Glulisine to Insulin Lispro.

 Secondary:

 -  To compare Insulin Glulisine to Insulin Lispro in terms of the change in HbA1c at weeks
 12, blood glucose parameters, insulin doses and treatment satisfaction in subjects with
 type 1 or type 2 diabetes mellitus
Inclusion Criteria:

 -  Type 1 or type 2 diabetic patients

 -  Measure HbA1c 6.5% to 11.0% at visit 1

 -  More than 3 months of continuous insulin treatment immediately prior to study entry

 Exclusion Criteria:

 -  Pregnant women

 The above information is not intended to contain all considerations relevant to a patient's
 potential participation in a clinical trial.